Drug Shortage Report for ROFACT
| Report ID | 116496 |
| Drug Identification Number | 00393444 |
| Brand name | ROFACT |
| Common or Proper name | ROFACT |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | RIFAMPIN |
| Strength(s) | 150MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100's |
| ATC code | J04AB |
| ATC description | DRUGS FOR TREATMENT OF TUBERCULOSIS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | |
| Actual start date | 2020-05-29 |
| Estimated end date | |
| Actual end date | 2020-07-10 |
| Shortage status | Resolved |
| Updated date | 2020-07-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-07-27 | French | Compare |
| v5 | 2020-07-27 | English | Compare |
| v4 | 2020-07-02 | French | Compare |
| v3 | 2020-07-02 | English | Compare |
| v2 | 2020-06-03 | French | Compare |
| v1 | 2020-06-03 | English | Compare |
Showing 1 to 6 of 6